Tarsus Pharmaceuticals, Inc. (TARS)
61.58
+1.94
(+3.26%)
USD |
NASDAQ |
Jun 09, 16:00
61.58
0.00 (0.00%)
After-Hours: 20:00
Tarsus Pharmaceuticals SG&A Expense (Quarterly) : 136.43M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Structure Therapeutics, Inc. | 22.94M |
| Eton Pharmaceuticals, Inc. | 10.45M |
| Alumis, Inc. | 18.61M |
| Veradermics, Inc. | 8.937M |
| ANI Pharmaceuticals, Inc. | 73.66M |